☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Plus Therapeutics
Plus Therapeutics’ Rhenium (186Re) Obisbemeda Received the US FDA’s Orphan Drug Designation to Treat Breast Cancer with Leptomenin...
November 6, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.